{"mainPropery":{"diseaseId":4881,"diseaseName":"Multiple endocrine neoplasia type 2A","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/4881/multiple-endocrine-neoplasia-type-2a","synonyms":["Sipple syndrome","MEN 2A","MEN-2A syndrome","Pheochromocytoma and amyloid producing medullary thyroid carcinoma","PTC syndrome"],"synonyms-with-source":[{"name":"Sipple syndrome"},{"name":"MEN 2A"},{"name":"MEN-2A syndrome"},{"name":"Pheochromocytoma and amyloid producing medullary thyroid carcinoma"},{"name":"PTC syndrome"}],"identifiers":[{"identifierType":"OMIM","identifierId":"171400"},{"identifierType":"ORPHANET","identifierId":"247698"},{"identifierType":"UMLS","identifierId":"C0025268"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":6,"diseaseTypeName":"Digestive Diseases","source":"Orphanet"},{"diseaseTypeId":8,"diseaseTypeName":"Endocrine Diseases","source":"Orphanet"},{"diseaseTypeId":28,"diseaseTypeName":"Hereditary Cancer Syndromes"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[{"resourceID":638,"resourceName":"Association for Multiple Endocrine Neoplasia Disorders (AMEND)","abbreviation":"UK, New Zealand, and USA","address1":"The Warehouse","address2":"No 1 Draper Street","address3":"Southborough","address4":"Tunbridge Wells Kent TN4 0PG","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"+ 44 (0)1892 516076","tty":"","tollFree":"","fax":"","email":"info@amend.org.uk","url":"http://www.amend.org.uk","freeText":""},{"resourceID":2417,"resourceName":"American Multiple Endocrine Neoplasia Support","abbreviation":"","address1":"1027 Hampshire Drive","address2":"","address3":"","address4":"","address5":"","city":"Maryville","state":"TN","zip":"37801","country":"","phone":"865-238-5842","tty":"","tollFree":"","fax":"","email":"http://amensupport.org/contact%20us","url":"http://www.amensupport.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/171400' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=171400' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Multiple endocrine neoplasia type 2A. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Multiple+endocrine+neoplasia+type+2A%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Multiple endocrine neoplasia type 2A. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/multiple-endocrine-neoplasia' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Multiple endocrine neoplasia type 2A. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/multiple-endocrine-neoplasia' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1244/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000399.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/123447-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=247698' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1257/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merckmanuals.com/home/print/sec13/ch167/ch167a.html' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:171400' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":4077,"questionText":"What is&nbsp;multiple endocrine neoplasia type 2A?","answerText":"<strong>Multiple endocrine neoplasia type 2A</strong> (MEN 2A)<strong> </strong>is is an inherited disorder caused by mutations in the <em><a href=\"http://ghr.nlm.nih./\" target=_blank>RET</a></em> gene.[3021] Individuals with MEN 2A are at high risk of developing <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000374.htm\" target=_blank>medullary carcinoma of the thyroid</a>. About 50% will develop <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000340.htm\" target=_blank>pheochromocytoma</a>, a tumor of the adrenal glands which may increase blood pressure.&nbsp;Individuals with MEN 2A are also at increased risk for <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001188.htm\" target=_blank>parathyroid adenoma</a> or hyperplasia (overgrowth of the parathyroid gland).[3022][3023] Occasionally an itchy skin condition called cutaneous lichen amyloidosis also occurs in people with type 2A disease.[3023] The condition is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> manner.[3021]","dateModified":"2011-02-11T15:30:00"},"basicQuestions":[{"questionId":4079,"questionText":"How is&nbsp;multiple endocrine neoplasia type 2A inherited?","answerText":"Multiple endocrine neoplasia type 2A (MEN 2A) is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> pattern. A person with&nbsp;MEN 2A&nbsp;often inherits the altered <span class=geneSymbol><em><a href=\"http://ghr.nlm.nih./\" target=_blank>RET</a></em></span> gene from one parent with the condition.[3021]&nbsp;&nbsp;","dateModified":"2011-02-11T15:33:00","resourceClassificationName":"Inheritance","references":[{"referenceId":3021,"authors":"","articleTitle":"Multiple endocrine neoplasia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2006","url":"http://ghr.nlm.nih.gov/condition/multiple-endocrine-neoplasia","dateAccessed":"2011-02-11T00:00:00"}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":29454,"abbreviatedInquiry":"How rare is multiple endocrine neoplasia type 2A? How is this condition&nbsp;inherited?","caseQuestions":[{"questionId":4078,"questionText":"How rare is&nbsp;multiple endocrine neoplasia type 2A?","answerText":"Multiple endocrine neoplasia type 2 affects an estimated 1 in 30,000 to 35,000&nbsp;people. Among the subtypes of multiple endocrine neoplasia type 2, type 2A is the most common form, making up 70-80% of cases.[3021][3022] ","dateModified":"2011-02-11T15:32:00","references":[{"referenceId":3021,"authors":"","articleTitle":"Multiple endocrine neoplasia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2006","url":"http://ghr.nlm.nih.gov/condition/multiple-endocrine-neoplasia","dateAccessed":"2011-02-11T00:00:00"},{"referenceId":3022,"authors":"Moline J, Eng C","articleTitle":"Multiple Endocrine Neoplasia Type 2","bookWebsiteJournalTitle":"GeneReviews","date":"2010","url":"http://www.ncbi.nlm.nih.gov/books/NBK1257/","dateAccessed":"2011-02-11T00:00:00"}]},{"questionId":4079,"questionText":"How is&nbsp;multiple endocrine neoplasia type 2A inherited?","answerText":"Multiple endocrine neoplasia type 2A (MEN 2A) is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> pattern. A person with&nbsp;MEN 2A&nbsp;often inherits the altered <span class=geneSymbol><em><a href=\"http://ghr.nlm.nih./\" target=_blank>RET</a></em></span> gene from one parent with the condition.[3021]&nbsp;&nbsp;","dateModified":"2011-02-11T15:33:00","resourceClassificationName":"Inheritance","references":[{"referenceId":3021,"authors":"","articleTitle":"Multiple endocrine neoplasia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"2006","url":"http://ghr.nlm.nih.gov/condition/multiple-endocrine-neoplasia","dateAccessed":"2011-02-11T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":7802,"phenoTypeName":"Medullary thyroid carcinoma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11831,"phenoTypeName":"Chest pain","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13250,"phenoTypeName":"Elevated urinary dopamine","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":12798,"phenoTypeName":"Elevated urinary epinephrine","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":3992,"phenoTypeName":"Elevated urinary norepinephrine","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13249,"phenoTypeName":"Elevated urinary vanillylmandelic acid","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11409,"phenoTypeName":"Headache","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6027,"phenoTypeName":"Hypertension","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13063,"phenoTypeName":"Palpitations","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13292,"phenoTypeName":"Pheochromocytoma","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4746,"phenoTypeName":"Abnormality of the integument","percentRanges":"-"},{"phenoTypeId":11214,"phenoTypeName":"Aganglionic megacolon","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":8368,"phenoTypeName":"Cutaneous lichen amyloidosis","percentRanges":"-"},{"phenoTypeId":13604,"phenoTypeName":"Elevated calcitonin","percentRanges":"-"},{"phenoTypeId":6045,"phenoTypeName":"Hyperparathyroidism","percentRanges":"-"},{"phenoTypeId":14565,"phenoTypeName":"Increased circulating cortisol level","percentRanges":"-"},{"phenoTypeId":4306,"phenoTypeName":"Parathyroid adenoma","percentRanges":"-"},{"phenoTypeId":12254,"phenoTypeName":"Thyroid C cell hyperplasia","percentRanges":"-"}],"medicalProducts":[{"productId":186,"genericName":"Iobenguane I 123","tradeName":"Adreviewâ„¢","tradeLink":"","manufacturer":"","sponsor":"GE Healthcare, Inc","indication":"To be used in the detection of primary or metastatic pheochromocytomas or neuroblastomas as an adjunct to other diagnostic tests","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Adreview","medlinePlusLink":""},{"productId":473,"genericName":"Iobenguane I 131","tradeName":"Azedra","tradeLink":"https://azedra.com/","manufacturer":"","sponsor":"Progenics Pharmaceuticals, Inc.","indication":"July 2018, iobenguane I 131 (Azedra) was approved for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive, unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/azedra","medlinePlusLink":""}],"EncodedName":"Multiple_endocrine_neoplasia_type_2A"}